Cargando…
137例单份非亲缘脐血造血干细胞移植患者的临床研究
OBJECTIVE: To evaluate relevant prognostic factors of unrelated single unit umbilical cord blood hematopoietic stem cell transplantation (sUCBT), and to explore the correlation between cryopreservation time of cord blood and cell viability and outcome of sUCBT. METHODS: Retrospective analysis of 137...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342165/ https://www.ncbi.nlm.nih.gov/pubmed/25778891 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.012 |
_version_ | 1783555391787892736 |
---|---|
collection | PubMed |
description | OBJECTIVE: To evaluate relevant prognostic factors of unrelated single unit umbilical cord blood hematopoietic stem cell transplantation (sUCBT), and to explore the correlation between cryopreservation time of cord blood and cell viability and outcome of sUCBT. METHODS: Retrospective analysis of 137 patients undergoing sUCBT with cord blood provided by Shanghai Cord Blood Bank from Mar. 15, 2007 to Dec. 26, 2013 were performed in this study. The mean cryopreservation time of 137 units cord blood was 698 (96-1968) days, with mean cell viability of 87.4% after thawing. RESULTS: No statistical difference on cell viability, hematopoietic reconstitution, graft failure, acute graft versus host disease (GVHD) and overall survival (OS) was found between patients transfused with cord blood preserved below and above 2 years. The 5-year OS of patients transfused with cord blood preserved below and above 2 years were 55.6% and 67.9%, respectively (P=0.124). OS of the UCBT at 2011 and before, and after 2011 was 48.7% and 79.6%, respectively (P=0.001). Age above 16-year-old (RR=2.830,P= 0.027) and UCBT at 2011 and before (RR=0.203,P<0.001) were two risk factors of treatment related mortality. CONCLUSION: Outcome of sUCBT in China had significant improvement in recent 2 years. Cryopreservation time of cord blood had no statistical correlation to cell viability after thawing and clinical outcome. |
format | Online Article Text |
id | pubmed-7342165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Editorial office of Chinese Journal of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-73421652020-07-16 137例单份非亲缘脐血造血干细胞移植患者的临床研究 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To evaluate relevant prognostic factors of unrelated single unit umbilical cord blood hematopoietic stem cell transplantation (sUCBT), and to explore the correlation between cryopreservation time of cord blood and cell viability and outcome of sUCBT. METHODS: Retrospective analysis of 137 patients undergoing sUCBT with cord blood provided by Shanghai Cord Blood Bank from Mar. 15, 2007 to Dec. 26, 2013 were performed in this study. The mean cryopreservation time of 137 units cord blood was 698 (96-1968) days, with mean cell viability of 87.4% after thawing. RESULTS: No statistical difference on cell viability, hematopoietic reconstitution, graft failure, acute graft versus host disease (GVHD) and overall survival (OS) was found between patients transfused with cord blood preserved below and above 2 years. The 5-year OS of patients transfused with cord blood preserved below and above 2 years were 55.6% and 67.9%, respectively (P=0.124). OS of the UCBT at 2011 and before, and after 2011 was 48.7% and 79.6%, respectively (P=0.001). Age above 16-year-old (RR=2.830,P= 0.027) and UCBT at 2011 and before (RR=0.203,P<0.001) were two risk factors of treatment related mortality. CONCLUSION: Outcome of sUCBT in China had significant improvement in recent 2 years. Cryopreservation time of cord blood had no statistical correlation to cell viability after thawing and clinical outcome. Editorial office of Chinese Journal of Hematology 2015-02 /pmc/articles/PMC7342165/ /pubmed/25778891 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.012 Text en 2015年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
spellingShingle | 论著 137例单份非亲缘脐血造血干细胞移植患者的临床研究 |
title | 137例单份非亲缘脐血造血干细胞移植患者的临床研究 |
title_full | 137例单份非亲缘脐血造血干细胞移植患者的临床研究 |
title_fullStr | 137例单份非亲缘脐血造血干细胞移植患者的临床研究 |
title_full_unstemmed | 137例单份非亲缘脐血造血干细胞移植患者的临床研究 |
title_short | 137例单份非亲缘脐血造血干细胞移植患者的临床研究 |
title_sort | 137例单份非亲缘脐血造血干细胞移植患者的临床研究 |
topic | 论著 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342165/ https://www.ncbi.nlm.nih.gov/pubmed/25778891 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.012 |
work_keys_str_mv | AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū |